secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2021-11-04T23:59:59+00:00
Accession:  0001104659-21-134376
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q3 revenue jumps 52% to $413M; EPS $3.56; coaches up 45%
-----------------------------------------------------------------

- Revenue increased 52.3% to $413.4M; net income $42.0M, diluted EPS $3.56 (up 22.3%).
- Active earning OPTA VIA coaches rose 44.9% to 61,000; revenue per coach $6,773 (up 7%).
- Gross profit margin 74.3% (vs 75.2% last year); SG&A as % of revenue rose to 60.9% from 58.7%.
- Full-year 2021 guidance: revenue $1.51B-$1.53B, EPS $13.27-$13.96.
- Cash and investments $159.9M; declared $1.42/share dividend payable Nov 8; $26.3M share repurchases in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000110465921134376/0001104659-21-134376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000110465921134376/tm2131984d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-134376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer